10.17.17
Pavel Lotkov has been appointed director of Product Management at Adents, a provider of serialization and track-and-trace solutions.
Mr. Lotkov will leverage his experience in implementing complex serialization solutions to enrich Adents Prodigi Cloud Solution, taking advantage of its cloud architecture based on Microsoft Azure. Mr. Lotkov will also work with potential customers providing necessary information to help them make informed decisions. He reports to Adents’ chief executive officer, Christophe Devins.
Mr. Lotkov brings more than 16 years of IT experience, as well as deep understanding of business operations in large pharmaceutical companies. Most recently, he led serialization adoption and implementation efforts at Eli Lilly, where he focused on regulatory requirements and business process analysis, risk impact assessment, system validation and solution provider management.
“Pavel’s experience managing all aspects of the serialization process for a major pharmaceutical company makes him a highly valuable addition to our team,” said Christophe Devins, chief executive officer of Adents. “For Big Pharma companies, serialization efforts represent major, mandatory initiatives requiring a significant investment of time and resources. Pavel’s comprehensive knowledge of the processes’ myriad intricacies means he knows how to help our customers make the best decisions for their specific business needs.”
Mr. Lotkov will leverage his experience in implementing complex serialization solutions to enrich Adents Prodigi Cloud Solution, taking advantage of its cloud architecture based on Microsoft Azure. Mr. Lotkov will also work with potential customers providing necessary information to help them make informed decisions. He reports to Adents’ chief executive officer, Christophe Devins.
Mr. Lotkov brings more than 16 years of IT experience, as well as deep understanding of business operations in large pharmaceutical companies. Most recently, he led serialization adoption and implementation efforts at Eli Lilly, where he focused on regulatory requirements and business process analysis, risk impact assessment, system validation and solution provider management.
“Pavel’s experience managing all aspects of the serialization process for a major pharmaceutical company makes him a highly valuable addition to our team,” said Christophe Devins, chief executive officer of Adents. “For Big Pharma companies, serialization efforts represent major, mandatory initiatives requiring a significant investment of time and resources. Pavel’s comprehensive knowledge of the processes’ myriad intricacies means he knows how to help our customers make the best decisions for their specific business needs.”